College of Pharmacy
In this section
HelixTalk Episode #32 - ARNIs and Entresto
Date posted: September 22, 2015, 6:00 am
In this episode, we discuss the new drug class, ARNI, recently approved for heart failure with a focus on sacubatril/valsartan (Entresto) and the PARADIGM-HF trial.